Restoring hearing with cochlear implants
Submitting Institution
University of SouthamptonUnit of Assessment
General EngineeringSummary Impact Type
HealthResearch Subject Area(s)
Medical and Health Sciences: Clinical Sciences, Neurosciences
Summary of the impact
Cochlear implants are the only successful treatment available for people
with severe to profound deafness. Research into these implants at the
Institute of Sound and Vibration Research (ISVR) at the University of
Southampton has led directly to changes in health policy, including new
guidelines by the National Institute for Health and Clinical Excellence
(NICE). ISVR researchers have developed patient assessment questionnaires
which are used internationally as a means of monitoring children with
cochlear implants. ISVR pioneered research and clinical work bilateral
cochlear implantations in the UK, yielding benefits for the estimated
9,000 bilateral cochlear implant recipients around the world (around 700
in the UK).
Underpinning research
Cochlear implants are the only successful treatment for people with
severe to profound deafness who cannot benefit from hearing aids. They can
completely change the lifetime prospects of a deaf baby, providing the
ability to hear and understand speech. At the University of Southampton's
ISVR, a team of researchers (Mark Lutman, Professor of Audiology since
1995, retired 2012; Julie Brinton, Head of the South of England Cochlear
Implant Centre since 1996; and Dr Carl Verschuur, Lecturer in Audiology
since 1999) have carried out crucial research into the benefits of
bilateral implantation, providing tools for clinical service, and
developing novel speech processors.
Cochlear implants can provide a striking improvement in quality of life
for children with severe to profound hearing loss. But clinical
examination, candidate selection and rehabilitation are much more
difficult for children than adults, especially very young children. As
part of clinical research to address these issues, Lutman and colleagues
developed the Categories of Auditory Performance (CAP) rating scale [1].This
is a reliable scale used to predict the performance of paediatric cochlear
implantation and rate outcomes from the treatment in everyday life [1].
In 2001 and 2002, they further developed the Parent Questionnaire (PARQ)
to assess parental views and experiences regarding children with cochlear
implants [2].These questionnaires can be reliably used for infants
less than 12 months old. To maximise the benefits of cochlear implants for
children, Lutman and colleagues undertook research to decide the best age
at which to implant. They found that children given implants early are far
more likely to go to mainstream schools than those given implants when
already in an educational setting (53% vs 6%). [3].
ISVR researchers have been at the forefront of research into bilateral
cochlear implantation. Until recently, individuals with severe to profound
deafness in both ears usually received a single cochlear implant. ISVR's
pioneering research trials with cochlear implant recipients helped to
define the criteria of candidacy for cochlear implants [4] and
showed definitive benefits of bilateral cochlear implantation for sound
localisation [5].Subsequently, ISVR was a partner — alongside the
Institute of Hearing Research at Nottingham University and the implant
producer, Cochlear® — in setting up and running a highly influential
national trial of bilateral cochlear implantation which showed significant
measurable advantages to providing two cochlear implants [5]. The
trial ran from 2000 to 2004. Researchers at the ISVR (Carl Verschuur and
Mark Lutman) ran the auditory localisation "wing" of the national study.
In parallel to the clinical research, the team conducted research to
improve speech processing in cochlear implants. Between 2006 and 2011,
Lutman and ISVR colleagues developed a novel speech coding strategy based
on providing a simpler speech signal to the implant recipient, known as
sparse representation [6].The ISVR is a major participant a
European-wide funded scheme to develop novel speech processing strategies
for cochlear implants [7].
References to the research
Selected ISVR publications (best three are starred)
[2] Archbold S, Lutman ME, Gregory S, O'Neill C, Nikolopoulos TP,
Parents and their deaf child: their perceptions three years after cochlear
implantation, Deafness Education International 4(1):12-40, 2002 http://eprints.soton.ac.uk/10641/
[4] UK Cochlear Implant Study Group. Criteria of candidacy for
unilateral cochlear implantation in postlingually deafened adults — I:
Theory and measures of effectiveness. Ear and Hearing 25(4), 310-35, 2004.
ISVR contributors included Lutman and Eyles.
http://www.ncbi.nlm.nih.gov/pubmed/15292774
[5]* Verschuur CA, Lutman ME, Ramsden R, Greenham P, O'Driscoll M.
Auditory localization abilities in bilateral cochlear implant recipients.
Otology & Neurotology 26(5), 965-71, 2005
http://eprints.soton.ac.uk/28305/
Patent
[6] Sparse stimulation for cochlear implant. UK patent number: WO
2009030909 20090312, Publication date: inventors: Mark Lutman; Guoping Li,
2009
http://patents.justia.com/patent/8290597
Grant
[7] Digital signal Processing in Audiology, European Marie Curie
Initial Training Networks (ITN) European Framework Programme 7, 2008-2012,
Mark Lutman. 2,950,000 €
Details of the impact
There are 10 million people with hearing loss in the UK and 0.2 million
with severe to profound hearing loss may require cochlear implants. Around
the world there are 220,000 people with cochlear implants. The research
carried out at ISVR has had a direct impact on the lives of such people,
as well as the quality of clinical service and national health policies
for cochlear implantation.
The ISVR research described in Section 2 has had a substantial impact on
UK national health policies. In 2009, the South of England Cochlear
Implant Centre (now University of Southampton Auditory Implant Service) at
the ISVR performed its first simultaneous bilateral cochlear implants, and
since then about 150 patients have received bilateral cochlear implants
nationally. The research led by ISVR on the benefits of bilateral cochlear
implants, and research on educational outcomes for children with implants — with ISVR as one of main contributors — were cited in the guideline
published by the National Institute for Health and Clinical Excellence
(NICE) [8, 9]. Lutman was invited to contribute to this guideline
on the basis of his expertise gained through the underpinning research.
The guideline recommends bilateral cochlear implantation for all children
and some adults.
The ISVR's research examining the best age for children to receive
implants provided direct evidence for designing other guidelines for
professionals dealing with deaf people, including national guidelines on
cochlear implantation for children and young people [10] used by
the 22 cochlear implant centres in the UK in their clinical work.
Similarly, the guidance Criteria of candidacy for unilateral cochlear
implantation in post-lingual deafened adult' (see section 3 of [3])
designed by several groups with substantial input from ISVR research and
published in 2004, continues to be widely used in most cochlear implant
centres in the UK.
The questionnaires developed by Lutman at ISVR have been widely used as
research and clinical tools. The CAP questionnaire has been translated
into at least 13 languages by The Ear Foundation of the UK [16].
It has become a standard assessment tool for patients with cochlear
implants in worldwide clinical centres and is widely used for patient
selection, performance prediction and outcome rating. Countries using the
questionnaire in clinical studies have included Thailand [11]; in
a study of 143 children, 164 children in Finland [12]; a study of
164 children receiving the devices; and a study of 44 children in China [13].
Both the CAP and the parent questionnaire, PARQ, have been used as indices
in the cost-effectiveness calculation for cochlear implantation, which is
a key factor influencing health policy [17], [18].
At the patient
level, ISVR has performed more than 500 unilateral implantations since
2008 and conducted the first pioneering bilateral implantation in the UK
in 2009, providing very significant quality of life improvements for each
of these patients and their families. More widely, ISVR's research has
indirectly improved clinical services through the policies and guidelines
mentioned above for about 11,000 existing and 1,000 new implant users per
year in the UK. Patients report exceptionally high levels of satisfaction
from clinical services provided by the ISVR. The following is typical of
self-report from such patients: "I still can't find words to express how
overjoyed I am with the result so far, and how appreciative I am of all
the help and understanding I've been given. I can now take an active part
in life again — truly "life after deaf". [14]
The life-changing nature of cochlear implants was celebrated and brought
to the attention of a wider public through a highly unusual public event
in Southampton in September 2012, a concert of musical works by Benjamin
Oliver specifically composed for cochlear implant users, attended by over
100 people [15]. The concert and musical piece led directly from
work conducted by ISVR researcher Rachel van Besouw (lecturer in
Audiology, working at ISVR since 2007) which has highlighted the
difficulties cochlear implant users experience.
Sources to corroborate the impact
[8] National Institute for Health and Clinical Excellence
Guideline: Cochlear implants for children and adults with severe to
profound deafness. 2009.
http://www.nice.org.uk/nicemedia/pdf/TA166Guidancev2.pdf
http://www.nice.org.uk/TA166
[9] Health Technology Appraisal 166: Cochlear Implants for
Deafness in Children and Adults
http://www.hta.ac.uk/fullmono/mon1344.pdf
[10] Quality Standards: Cochlear Implants for children and young
people — Guidelines for professionals working with deaf children (British
Cochlear Implant Group and the National Deaf Children's Society, 2009).
http://www.ndcs.org.uk/about_us/position_statements/cochlear_implants.html
[11] Kasemsuwan L, Cheewaruangroj W, Tungkeeratichai J,
Bhongmakapat T, Lertsukprasert K, Thawin C, Tiravanitchakul R, Dara R,
Orathai P Audiological outcomes of cochlear implantation in Ramathibodi
Hospital. Journal of the Medical Association of Thailand 2011 Nov
94(11):1380-6.
http://www.ncbi.nlm.nih.gov/pubmed/22256479
[12] Lonka E, Hasan M, Komulainen E Spoken language skills and
educational placement in Finnish children with cochlear implants. Folia of
Phoniatrica et Logopaedica 2011;63(6):296-304.
http://www.karger.com/Article/FullText/326911
[13] Zhou H, Chen Z, Shi H, Wu Y, Yin S Comparisons of auditory
performance and speech intelligibility in children with cochlear implants
placed using different approaches. Otology and Neurotology 2012
Jan;33(1):26-9.
[14] http://ais.southampton.ac.uk/personal-views/.
This website provides an overview of reported personal experiences from
users of the ISVR auditory implant service.
[15] http://www.southampton.ac.uk/mfg/current_projects/compositions.html.
The website provides an overview of joint ISVR-Department of Music
(University of Southampton) work to research music abilities in cochlear
implant recipients and develop novel musical compositions focused on the
listening needs of this population.
[16] Chief Executive, The Ear Foundation
[17] Chair of British Cochlear Implant Group, Yorkshire Cochlear
Implant Service, Bradford Royal Infirmary
[18] Professor Quentin Summerfield, Department of Psychology,
University of York